HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gleyson Kleber do Amaral-Silva Selected Research

Ribosomal Protein S6

11/2019Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gleyson Kleber do Amaral-Silva Research Topics

Disease

3Squamous Cell Carcinoma of Head and Neck
01/2023 - 04/2017
2Carcinogenesis
09/2017 - 04/2017
1Oropharyngeal Neoplasms
01/2023
1Oral Leukoplakia
11/2019
1Carcinoma (Carcinomatosis)
09/2017
1Ameloblastoma
09/2017
1Neoplasms (Cancer)
04/2017
1Mouth Neoplasms (Oral Cancer)
04/2017

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
09/2017 - 04/2017
1Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2019
1Ribosomal Protein S6IBA
11/2019

Therapy/Procedure

1Oral Pathology
01/2023